Literature DB >> 32490395

Two Cases of Infant Botulism Presenting with Altered Mental Status.

Marian August1, Mitchell Hamele1.   

Abstract

Infant botulism is a progressive process described as starting with descending weakness, facial palsies and constipation. Loss of bulbar reflexes and flaccid paralysis are common in infants less than 6 months old who have infant botulism. Clostridium botulinum, the bacteria that produce the toxin that causes this condition, are ubiquitous in the United States including Hawai'i, but infant botulism is rarely reported here. This report describes 2 cases of infant botulism with atypical initial presentations diagnosed on O'ahu, Hawai'i. Patient A is a 3-month-old male who presented with altered mental status, including inconsolability, who progressed to loss of gag reflex and constipation. Due to early concern for meningitis, Patient A was treated with antibiotics, however further evaluation led to eventual positive testing for botulinum B toxin. Patient B is a 2-month-old female who presented with somnolence and fever after immunizations and progressed to respiratory failure and apparent dehydration. Because she presented shortly after receiving immunizations, metabolic disorders were strongly considered as a potential cause of symptoms, but Patient B had normal metabolic evaluation and eventually tested positive for botulinum A toxin. Altered mental status and fever are unusual presentations for infant botulism. Infant botulism should be considered in infants with altered mental status when the course of illness includes the development of constipation and weakness, and evaluations are not suggestive of alternative causes, including infection, metabolic diseases, and spinal muscular atrophy. Early consideration and treatment of infant botulism should be considered for infants presenting with altered mental status who develop neuromuscular weakness. The Infant Botulism Treatment and Prevention Program (www.infantbotulism.org) should be contacted early for assistance with diagnosis and treatment. ©Copyright 2020 by University Health Partners of Hawai‘i (UHP Hawai‘i).

Entities:  

Keywords:  Infant botulism

Mesh:

Substances:

Year:  2020        PMID: 32490395      PMCID: PMC7260868     

Source DB:  PubMed          Journal:  Hawaii J Health Soc Welf        ISSN: 2641-5216


  6 in total

Review 1.  Botulism.

Authors:  Maria A Carrillo-Marquez
Journal:  Pediatr Rev       Date:  2016-05

2.  More Clinical Mimics of Infant Botulism.

Authors:  Jessica M Khouri; Jessica R Payne; Stephen S Arnon
Journal:  J Pediatr       Date:  2017-12-08       Impact factor: 4.406

Review 3.  Recent advances in infant botulism.

Authors:  Christine K Fox; Corinne A Keet; Jonathan B Strober
Journal:  Pediatr Neurol       Date:  2005-03       Impact factor: 3.372

Review 4.  Infant botulism and indications for administration of botulism immune globulin.

Authors:  Elysha Pifko; Amanda Price; Sarah Sterner
Journal:  Pediatr Emerg Care       Date:  2014-02       Impact factor: 1.454

5.  Acute infantile motor unit disorder. Infantile botulism?

Authors:  S A Clay; J C Ramseyer; L S Fishman; R P Sedgwick
Journal:  Arch Neurol       Date:  1977-04

6.  Infant botulism: a 30-year experience spanning the introduction of botulism immune globulin intravenous in the intensive care unit at Childrens Hospital Los Angeles.

Authors:  Karen Underwood; Sarah Rubin; Timothy Deakers; Christopher Newth
Journal:  Pediatrics       Date:  2007-12       Impact factor: 7.124

  6 in total
  1 in total

1.  Botulism outbreak in a rural Ethiopia: a case series.

Authors:  Tigist Bacha; Ermias Abebaw; Ayalew Moges; Amsalu Bekele; Afework Tamiru; Ishmael Shemsedin; Dawd S Siraj; Daddi Jima; Wondwossen Amogne
Journal:  BMC Infect Dis       Date:  2021-12-20       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.